International Journal of Cancer · 1999 · 31 citations · 21 references
MedicineCancer BiologyOncologyMolecular OncologyNeoplasiaNeuro-oncologyCancer Cell SignalingCancer TranscriptomicsEwing SarcomaMolecular Tumor ProfilingBinding AssaysCompetitive AssaysCompetitive Binding AssaysHormone Binding AffinityPeripheral Primitive Neuroectodermal TumorQuantitative AutoradiographyTumor Cell ProliferationVasoactive Intestinal Peptide Signaling
Vasoactive intestinal peptide (VIP) is a neuromodulator and growth regulator in the developing nervous system. We analyzed 10 primitive neuroectodermal tumor (PNET) cell lines, 29 central PNET (cPNET) and 17 tumors of the Ewing's sarcoma/peripheral PNET family (ESFT) using reverse transcriptase-polymerase chain reaction (RT-PCR) and Southern hybridization. Each of the 10 cell lines and 86.2% of cPNET expressed mRNA for VIP receptor 1 (VIPR1) compared to 52.9% of ESFT. VIPR2 was expressed in 75.8% of cPNET, in 28.6% of ESFT and in all 10 cell lines. cPNET demonstrated high-affinity binding of 125I-VIP on quantitative autoradiography and in competitive binding assays. VIP inhibited tumor cell proliferation in a dose-dependent manner in 5 of 7 PNET cell lines. We conclude that VIPR1 and VIPR2 are highly expressed in cPNET and demonstrate that VIP is a growth modulator in these tumors.
21
Inge M. Ambros, Peter F. Ambros, Sabine Strehl et al. · Cancer · 1991 · 657 citations · Full text
Life Sciences, Genetics, Oncology +17
Principles and Practice of Pediatric Oncology
Richard Labotka · JAMA · 1997 · 638 citations
Medicine, Oncology, Pediatrics +12
M E Foti, Mary Anne Mennite, Heide M. Pusztay et al. · 1992 · 561 citations
Life Sciences, Biology, Cell Biology +10
Raymond K. Mulhern, James L. Kepner, Patrick R. Thomas et al. · Journal of Clinical Oncology · 1998 · 399 citations
Medicine, Oncology, Pediatrics +17
Martín Villalba, Joël Bockaert, Laurent Journot · Journal of Neuroscience · 1997 · 331 citations · Full text